Otsuka Holdings Co., Ltd. (OTSKF)
| Market Cap | 28.17B |
| Revenue (ttm) | 16.65B |
| Net Income (ttm) | 2.83B |
| Shares Out | n/a |
| EPS (ttm) | 5.29 |
| PE Ratio | 9.94 |
| Forward PE | n/a |
| Dividend | 0.96 (2.16%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 200 |
| Average Volume | 42 |
| Open | 44.40 |
| Previous Close | 44.40 |
| Day's Range | 44.40 - 44.40 |
| 52-Week Range | 39.48 - 66.15 |
| Beta | 0.07 |
| RSI | 18.59 |
| Earnings Date | Jul 31, 2025 |
About Otsuka Holdings
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]
Financial Performance
In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.
Financial numbers in JPY Financial StatementsNews
Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript
Otsuka Corporation (OTCPK:OSUKF) Q1 FY2025 Earnings Conference Call August 1, 2025 2:30 AM ET Company Participants Yuji Otsuka - CEO, President, Chairman & MM Division Chief Yuji Otsuka I am Otsuka of...